/ Print /

HOSPITAL & PROVIDER STRATEGY

Three Ways Healthcare Organizations Can Improve Care ManagementHere are three strategies to navigate toward next-generation care management and increase member engagement in the process
Three Barriers to Biosimilar AdoptionUnderstanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.
How telemedicine will change care delivery and costs in 2018Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.
Some Consumers Set to Receive Complimentary Cancer Genomic ProfilingShift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.
Amazon, JPMorgan, Berkshire Hathaway collaboration puts insurers ‘on notice’Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.
Seven Ways to Help Patients Access Costly Cancer DrugsTwo new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Top Considerations in Pediatric Cancer Treatment: What Payers Should KnowA Stanford expert describes ideal treatment locations, common barriers, and how payers could better support patients and families.
How the Flu’s Severity Will Affect Healthcare SpendingThe flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
Four pain management programs curbing the opioid epidemicFrom State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy ChangesHow are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.